JMJ705 Antibody

What is JMJ705 and what is its primary function in plants?

JMJ705 is a Jumonji C domain protein from rice (Oryza sativa) that functions as a histone lysine demethylase, specifically reversing H3K27me2/3 methylation marks . This epigenetic regulator plays a critical role in plant defense mechanisms by modulating the expression of stress-responsive genes. The removal of repressive H3K27me3 marks from defense-related genes enables their activation during pathogen challenges, contributing to the plant's immune response system.

How is JMJ705 expression regulated during stress responses?

JMJ705 expression is highly responsive to various stress signals. RT-PCR analysis has shown that JMJ705 is expressed in all rice tissues, with relatively higher levels in leaves . Its expression is significantly induced by:

• Salt stress (NaCl)

• Plant hormones including abscisic acid, ethylene (ACC), and jasmonic acid (JA)

• Pathogen infection (particularly Xanthomonas oryzae pv. oryzae)

During pathogen infection, JMJ705 mRNA levels increase 8-10 fold within 12 hours post-inoculation in both susceptible and resistant rice varieties, indicating its fundamental role in biotic stress responses .

What experimental evidence confirms JMJ705's histone demethylase activity?

Multiple experimental approaches have validated JMJ705's demethylase activity:

• In vitro enzymatic assays demonstrated its ability to remove methyl groups from H3K27me2/3.

• Transient expression of JMJ705-FLAG-HA fusion protein in tobacco leaf cells followed by immunostaining showed clear reduction of H3K27me2 levels in nuclei expressing the fusion protein, while other histone marks (H3K9me2, H3K4me3, H3K36me1, H3K36me2) remained unchanged .

• Overexpression studies in rice showed reduced global levels of H3K27me2/3, particularly at stress-responsive gene loci.

These complementary approaches confirm that JMJ705 functions specifically as an H3K27me2/3 demethylase in plant cells.

How can researchers optimize chromatin immunoprecipitation (ChIP) assays using JMJ705 antibodies?

Optimizing ChIP assays with JMJ705 antibodies requires careful attention to several parameters:

When performing ChIP with JMJ705 antibodies, researchers should first validate the antibody using Western blots with samples from wild-type and JMJ705 overexpression plants to confirm specificity before proceeding to ChIP applications .

What are the key considerations when designing experiments to study JMJ705's role in pathogen response?

When investigating JMJ705's function in pathogen response, researchers should implement:

• Comprehensive genetic resources:

  • JMJ705 overexpression lines

  • JMJ705 knockout/knockdown mutants

  • Complementation lines to verify phenotypes

• Time-course experiments:

  • Collect samples at multiple timepoints (0, 6, 12, 24, 48, 72 hours post-infection)

  • Measure both JMJ705 expression and H3K27me3 levels at target genes

  • Monitor target gene expression changes in parallel

• Pathogen challenges:

  • Use multiple pathogen strains (e.g., different Xoo isolates like PXO99 and PXO347)

  • Quantify both disease symptoms (lesion area) and pathogen growth rates

  • Include resistant and susceptible varieties for comparison

• Integration with hormone signaling:

  • Compare pathogen response with methyl jasmonate treatment

  • Analyze overlap between JMJ705-regulated and hormone-responsive genes

  • Test JMJ705 function in hormone signaling mutant backgrounds

• Genome-wide analyses:

  • Perform ChIP-seq for JMJ705 binding and H3K27me3 distribution

  • Conduct RNA-seq to identify all differentially expressed genes

  • Integrate datasets to identify direct vs. indirect targets

Previous research has demonstrated that JMJ705 overexpression enhances resistance to bacterial blight disease caused by Xanthomonas oryzae, with transgenic plants showing reduced lesion areas (10-30% compared to 35-45% in wild-type) and slower pathogen growth rates .

How do H3K27me3 levels correlate with gene activation in JMJ705 overexpression studies?

Analysis of genome-wide H3K27me3 distribution in relation to JMJ705-mediated gene activation reveals:

ChIP assays examining specific upregulated genes confirmed reduced H3K27me3 levels near their transcription start sites in JMJ705 overexpression plants, while other histone marks remained largely unchanged . This pattern demonstrates that JMJ705 preferentially activates genes that are normally repressed by H3K27me3 marks, particularly those involved in stress responses.

What are the best practices for validating antibody specificity for JMJ705 detection?

Rigorous validation of JMJ705 antibodies should include:

• Western blot analysis:

  • Compare samples from wild-type, JMJ705 overexpression, and jmj705 mutant plants

  • Confirm single band of expected molecular weight (~120 kDa)

  • Verify increased signal intensity in overexpression lines and absent/reduced signal in mutants

• Immunoprecipitation tests:

  • Perform IP followed by Western blot (IP-WB)

  • Consider IP-mass spectrometry to confirm protein identity

  • Check for co-precipitation of known interacting proteins

• Epitope competition assays:

  • Pre-incubate antibody with immunizing peptide/protein

  • Verify signal elimination in Western blot and immunostaining

  • Test with related JmjC domain proteins to assess cross-reactivity

• Immunolocalization studies:

  • Compare nuclear localization patterns in different genetic backgrounds

  • Co-stain with DAPI to confirm nuclear localization

  • Use confocal microscopy to assess subnuclear distribution patterns

• Functional assays:

  • Test antibody's ability to inhibit JMJ705 enzymatic activity in vitro

  • Perform chromatin immunoprecipitation followed by qPCR of known target genes

  • Compare results with different antibodies targeting distinct JMJ705 epitopes

In published studies, antibodies against JMJ705 have been validated through transient expression of tagged versions of the protein, allowing parallel detection with both anti-tag and anti-JMJ705 antibodies to confirm specificity .

What approaches can be used to study the dynamics of JMJ705-mediated H3K27me3 demethylation during stress responses?

To capture the dynamic nature of JMJ705-mediated epigenetic changes during stress:

• Sequential ChIP (Re-ChIP):

  • First IP with JMJ705 antibody, then IP eluate with H3K27me3 antibody

  • Identifies regions where both JMJ705 and H3K27me3 are present

  • Reveals transitional chromatin states during demethylation

• Time-resolved ChIP-seq:

  • Perform ChIP-seq for JMJ705 and H3K27me3 at multiple timepoints after stress

  • Map temporal changes in binding and methylation patterns

  • Integrate with RNA-seq to correlate with transcriptional changes

• Inducible JMJ705 expression systems:

  • Generate plants with chemically-inducible JMJ705 expression

  • Track H3K27me3 removal kinetics after induction

  • Determine minimum time required for demethylation effects

• Single-cell epigenomic profiling:

  • Apply single-cell ChIP-seq or CUT&Tag methods

  • Capture cell-type specific responses to stress

  • Identify pioneer cells that respond first to stress signals

• In vitro demethylation assays:

  • Purify recombinant JMJ705 protein

  • Test demethylation activity on nucleosome substrates

  • Measure reaction kinetics under different conditions

Research has shown that JMJ705 is involved in methyl jasmonate-induced dynamic removal of H3K27me3 from responsive genes, suggesting it contributes to sustained activation of defense-related genes during biotic stress .

How can researchers distinguish between direct and indirect effects of JMJ705 activity?

Differentiating direct from indirect effects requires multiple complementary approaches:

Microarray analysis of JMJ705 overexpression lines identified 301 upregulated and 105 downregulated genes, with significantly enriched representation of stress-responsive genes among the upregulated set (89 of 301; P < 0.001) . The preferential upregulation of H3K27me3-marked genes in these plants strongly supports direct regulation through demethylase activity.

What troubleshooting strategies can address weak or non-specific signals when using JMJ705 antibodies in immunoblotting?

When encountering issues with JMJ705 antibody performance in Western blots:

• For weak signals:

  • Increase protein loading amount (50-100 μg total protein)

  • Extend primary antibody incubation (overnight at 4°C)

  • Use signal enhancement systems (e.g., biotin-streptavidin amplification)

  • Try alternative extraction buffers to improve protein solubilization

  • Reduce washing stringency slightly while maintaining specificity

• For non-specific bands:

  • Increase blocking stringency (5% BSA or 5% milk, 1-2 hours)

  • Optimize primary antibody dilution (test range from 1:500-1:5000)

  • Increase wash buffer stringency (0.1-0.3% Tween-20, higher salt)

  • Pre-adsorb antibody with plant extract from jmj705 mutant

  • Use freshly prepared samples with complete protease inhibitor cocktails

• Sample preparation considerations:

  • Include epigenetic enzyme inhibitors during extraction

  • Test different tissue types (JMJ705 is higher in leaves)

  • Compare nuclear extracts vs. whole cell lysates

  • Consider native vs. denaturing conditions based on epitope location

When detecting JMJ705 in stressed tissues, researchers should account for the significant upregulation that occurs after pathogen infection (8-10 fold increase) and adjust detection parameters accordingly .

What is the optimal experimental design for identifying JMJ705 target genes using antibody-based approaches?

To comprehensively identify JMJ705 target genes:

• Multi-omics integration:

  • Perform JMJ705 ChIP-seq to identify binding sites

  • Conduct H3K27me3 ChIP-seq in wild-type and JMJ705-OX plants

  • Generate RNA-seq data from the same tissues/conditions

  • Develop computational pipeline to integrate all three datasets

• Target validation strategy:

  • Primary screen: Identify genes with JMJ705 binding, H3K27me3 reduction, and expression increase

  • Secondary validation: Perform ChIP-qPCR on 10-15 candidate targets

  • Functional confirmation: Test expression changes in multiple genetic backgrounds

• Differential binding analysis:

  • Compare JMJ705 binding patterns under normal and stress conditions

  • Identify stress-specific recruitment sites

  • Correlate with dynamic changes in H3K27me3 levels

• Chromosome conformation analysis:

  • Combine ChIP with chromosome conformation capture (ChIP-3C)

  • Identify long-range interactions between JMJ705-bound enhancers and target promoters

  • Map three-dimensional epigenetic regulation networks

Previous microarray analysis revealed that genes upregulated in JMJ705 overexpression plants were significantly enriched for H3K27me3 marks (38.9% compared to genome-wide average) and for stress-responsive functions (89 of 301 genes; P < 0.001) .

How can JMJ705 antibodies be utilized to study cross-talk between histone modifications in plant defense mechanisms?

JMJ705 antibodies provide valuable tools for investigating epigenetic cross-talk:

• Sequential ChIP approaches:

  • Perform JMJ705 ChIP followed by H3K27me3 ChIP (or reverse order)

  • Extend to other modifications (H3K4me3, H3K36me3, acetylation marks)

  • Map combinatorial patterns at defense-related genes

• Protein complex analysis:

  • Use JMJ705 antibodies for co-immunoprecipitation

  • Identify interacting proteins via mass spectrometry

  • Determine if JMJ705 associates with readers or writers of other histone marks

• Comparative epigenomic profiling:

  • Map multiple histone modifications in wild-type vs. JMJ705-OX plants

  • Identify compensatory changes in other modifications when H3K27me3 is reduced

  • Construct comprehensive epigenetic signatures of defense genes

• Developmental context analysis:

  • Study modification patterns across different tissues and developmental stages

  • Determine if JMJ705 activity influences different modifications in context-specific ways

  • Examine if pathogen response alters these relationships

Analysis of ChIP-seq data has shown that genes upregulated by JMJ705 overexpression typically have high H3K27me3 and low H3K4me3 levels, suggesting these modifications may work antagonistically in regulating stress-responsive genes .

What are the emerging technologies for studying JMJ705 function that rely on antibody-based detection?

Novel antibody-dependent technologies applicable to JMJ705 research include:

• CUT&Tag (Cleavage Under Targets and Tagmentation):

  • Higher sensitivity than traditional ChIP

  • Requires fewer cells/less tissue

  • Can be adapted for single-cell analysis

  • Ideal for mapping JMJ705 binding with greater precision

• APEX proximity labeling:

  • Fuse APEX2 enzyme to JMJ705

  • Capture transient protein interactions in living cells

  • Identify complete JMJ705 interactome in different conditions

  • Requires antibodies for validation of interactions

• Live-cell imaging with nanobodies:

  • Develop fluorescently labeled anti-JMJ705 nanobodies

  • Track JMJ705 dynamics in living plant cells

  • Monitor recruitment to chromatin during stress responses

  • Observe real-time changes in nuclear distribution

• Targeted protein degradation:

  • Create anti-JMJ705 antibody-based degraders

  • Achieve rapid, inducible protein depletion

  • Study acute loss of JMJ705 function

  • Complement genetic approaches with temporal control

• Bivalent antibody-based chromatin readers:

  • Develop synthetic chromatin readers using anti-JMJ705 antibody fragments

  • Map co-occurrence of JMJ705 with specific histone modifications

  • Create novel tools for manipulating JMJ705 recruitment

These emerging technologies could significantly advance our understanding of how JMJ705 dynamically regulates H3K27me3 levels during plant stress responses.